Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Deferred Taxes (2016 - 2025)

Medifast (MED) has disclosed Deferred Taxes for 16 consecutive years, with $12.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Deferred Taxes rose 261.05% year-over-year to $12.1 million, compared with a TTM value of $11.5 million through Dec 2025, up 254.8%, and an annual FY2025 reading of $11.5 million, up 254.8% over the prior year.
  • Deferred Taxes was $12.1 million for Q4 2025 at Medifast, up from -$648000.0 in the prior quarter.
  • Across five years, Deferred Taxes topped out at $12.1 million in Q4 2025 and bottomed at -$7.5 million in Q4 2024.
  • Average Deferred Taxes over 5 years is $44928.6, with a median of $0.0 recorded in 2025.
  • The sharpest move saw Deferred Taxes soared 716.06% in 2023, then plummeted 711.32% in 2025.
  • Year by year, Deferred Taxes stood at -$3.7 million in 2021, then surged by 122.13% to $822000.0 in 2022, then skyrocketed by 716.06% to $6.7 million in 2023, then plummeted by 212.08% to -$7.5 million in 2024, then surged by 261.05% to $12.1 million in 2025.
  • Business Quant data shows Deferred Taxes for MED at $12.1 million in Q4 2025, -$648000.0 in Q3 2025, and -$20000.0 in Q2 2025.